<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>ijcicr</PublisherName>
<JournalTitle>International Journal of Clinical Investigation and Case Reports</JournalTitle>
<PISSN>C</PISSN>
<EISSN>l</EISSN>
<Volume-Issue>Volume 1, Issue 2</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>(Aug-Oct)</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>2022</Year>
<Month>08</Month>
<Day>23</Day>
</PubDate>
<ArticleType>Endocrinology</ArticleType>
<ArticleTitle>Impact of COVID-19 Restrictions on Outcomes of Patients with Cholelithiasis during the Pandemic</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>39</FirstPage>
<LastPage>44</LastPage>
<AuthorList>
<Author>
<FirstName>Constanza S.</FirstName>
<LastName>Pereyra</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
<FirstName>Franco J.</FirstName>
<LastName>Ortiz</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Manque F.</FirstName>
<LastName>Mozetic</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Cecilia L.</FirstName>
<LastName>Sforza</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Daniel</FirstName>
<LastName>E.Tripoloni</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Marcelo J.</FirstName>
<LastName>Fasano</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Marina A.</FirstName>
<LastName>Antelo</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Alberto R. Ferreres*</FirstName>
<LastName>(ARGENTINA)</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI>10.55828/ijcicr-12-08</DOI>
<Abstract>Introduction: The COVID-19 pandemic restrictions forced the postponement of most elective surgeries for pathologies that did not represent an imminent risk to life. This delay caused significantly higher Re-admission and complication rates in patients with cholelithiasis during the pandemic, compared to those who presented before the pandemic (p-value=0.0001).
Objective: To evaluate the impact of delayed surgical management of symptomatic gallstones, during the Covid-19 pandemic, on the complication and re-admission rates.
Design type: a descriptive retrospective.
Method: A cohort of patients hospitalized with pancreatobiliary pathology during the pandemic was compared to a control group who presented before the pandemic. Two groups were compared for the incidence of gallstone complications and re-admission rates. Primary or secondary neoplastic pathologies associated with gallstones were excluded.
Results: During the pre-pandemic period, between March 2019 and March 2020, a total of 408 patients with pancreatobiliary pathology were hospitalized. Out of 408 patients, 204 (50%) were admitted with acute biliary cholecystitis, 132 patients with acute pancreatitis (32.4%), and 72 patients with extrahepatic cholestasis (17.6%). 324 (79%) patients underwent surgery and 36 (8.82%) patients out of the remaining 84 (20.6%) patients were readmitted. The average hospital stay for patients with surgery was 4 days ---PlusMinusSymbol--- 1.6 days, while for those with non-surgical treatment was 7 days ---PlusMinusSymbol--- 1.4 days. From March 2020 to March 2021, a total number of 536 patients were hospitalized, including 252 (47%) with acute biliary cholecystitis, 144 (26.9%) with acute pancreatitis, and 128 (23.9%) with extrahepatic cholestasis and 12 with acute cholangitis (2.2%). 308 (57.5%) patients underwent surgery and 104 (19.4%) patients of the remaining 228 (42.5%) patients were readmitted. The average hospital stay for patients with surgery was 3 days ---PlusMinusSymbol--- 1.3 days, while for those with non-surgical treatment was 7 days ---PlusMinusSymbol--- 1.5 days.
Conclusions: The comparison of both groups showed a higher incidence of gallstone complications during the pandemic, associated with the preference of medical over surgical management. The higher incidence of complications were seen and associated with a decrease in the number of scheduled laparoscopic cholecystectomies.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>COVID-19,Gallstones,Evolutionary Complications,Difficult Laparoscopic Cholecystectomy,Cholelithiasis</Keywords>
<URLs>
<Abstract>https://ijcicr.com/ubijournal-v1copy/journals/abstract.php?article_id=14061&title=Impact of COVID-19 Restrictions on Outcomes of Patients with Cholelithiasis during the Pandemic</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>Campanile FC, Podda M, Arezzo A, et al. Acute cholecystitis during COVID-19 pandemic: A multi society position statement. World J Emerg Surg. 2020;15(1):38.
Martand;iacute;nez Caballero J, Gonzand;aacute;lez Gonzand;aacute;lez L, Rodrand;iacute;guez Cuand;eacute;llar E, et al. Multicentre cohort study of acute cholecystitis management during the COVID-19 pandemic. Eur J Trauma Emerg Surg. 2021;47(3):683-692.
Wakabayashi G, Iwashita Y, Hibi T, et al. Tokyo Guidelines 2018: surgical management of acute cholecystitis: safe steps in laparoscopic cholecystectomy for acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):73?86.
Kabir T, Kam JH, Chew MH. Cholecystectomy during the COVID-19 pandemic: current evidence and an understanding of the “new” critical view of safety: Correspondence. International Journal of Surgery. 2020; 79: 307-308.
Tommaso MM, Angelico R, Parente A, et al. Global management of a common, underrated surgical task during the COVID-19 pandemic: Gallstone disease-An International survery. Ann Med Sur. 2020;57:95-102.
Almora CCL, Arteaga PY, et al. Clinical and epidemiological diagnosis of bladder stone. Medical literature review. Rev Ciencias Mand;eacute;dicas. 2012;16:200-214.
Cai JS, Qiang S, Bao-Bing Y. Advances of recurrent risk factors and management of choledocholithiasis. Scand J Gastroenterol. 2017;52(1):34-43.
Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol. 2018;34(2):81-89.
Carraro A, Mazloum DE, Bihl F. Health-related quality of life outcomes after cholecystectomy. World J Gastroenterol. 2011;17(45):4945-4951.
Mayumi T, Okamoto K, Takada T, Strasberg SM, Solomkin JS, Schlossberg D, and Miura F. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2017;25(1):96-100.
Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):31-40.
Mukai S, Itoi T, Baron TH, et al. Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018. J Hepatobiliary Pancreat Sci. 24(10):537-549.
Okamoto K, Suzuki K, Takada T, et al. Tokyo Guidelines 2018: flowchart for the management of acute cholecystitis. J Hepatobiliary Pancreat Sci. 2018;25(1):55-72.
Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis. J HepatoBiliary Pancreat Sci. 2018;25(1):41-54.
Banks PA, Bollen TL, Dervenis C, et al. Acute Pancreatitis Classification Working Group. Classification of acute pancreatitis 2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102-111.
Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis. J Hepatobiliary Pancreat Sci. 2018; 25(1):17-30.
Fu SJ, George EL, Maggio PM, et al. The consequences of delaying elective surgery: surgical perspective. Ann Surg. 202;272(2):e79-e80.
https://apps.who.int/iris/handle/10665/331561
Isherwood J, Karki B, Chung WY, et al. Outcomes of gallstone complications during the COVID pandemic. Br J Surgery. 2021;108(1):e29-e30.
https://www.rcseng.ac.uk/coronavirus/joint-guidance-for-surgeons-v2
https://www.facs.org/for-medical-professionals/covid-19/clinical-guidance/triage
Wong LE, Hawkins JE, Langness S, et al. Where are all the patients? Addressing Covid-19 fear to encourage sick patients to seek emergency care. NEYM Catalyst. 2020.
Pirracchio R, Mavrothalassitis O, Mathis M. Response of US hospitals to elective surgical cases in the COVID-19 pandemic. Br J Anaesth. 2020;126(1):e46-e48.
Bozovich G, Alves DLA, Fosco M. Daand;ntilde;o colateral de la pandemia por Covid-19 en centros privados de salud de Argentina. Medicina. 2020;80:37-41.
Manzia TM, Angelico R, Parente A, Muiesan P, Tisone G. Global management of a common, underrated surgical task during the COVID-19 pandemic: Gallstone disease-An international survery. Ann Med Surg (Lond). 2020;57:95-102.
European association for the study of the liver (EASL) Clinical practice guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol. 2016;65(1):146-181.
Tazuma S, Unno M, Igarashi Y, et al. Evidence-based clinical practice guidelines for cholelithiasis 2016. J Gastroenterol. 2017;52(3):276-300.
Roberts SE, Morrison-Rees S, John A, Williams JG, Brown TH, and Samuel DG. The incidence and etiology of acute pancreatitis across Europe. Pancreatology. 2017;17(2):155-165.
Said-Degerli M, Hogir A, Kandaz OF, et al. How correct is the postponed cholecystectomy during the coronavirus disease-19 pandemic process? Gallstone ileus is not a myth anymore. Cir Cir. 2021;89:390-393.
https://normas.gba.gob.ar/ar-b/resolucion/2021/1297/234566
https://facme.es/wp-content/uploads/2020/03/AEC-Recomendaciones_AEC_en_CIRUGIA_DE_URGENCIAS1.pdf
Salazar M, Ituarte C, Abriata MG, Santoro F, Arroyo G. Gallbladder cancer in South America: epidemiology and prevention. Chin Clin Oncol. 2019;8(4):32.
https://www.equator-network.org/reporting-guidelines/strobe/
Yawar B, Marzouk A, Ali H, et al. Acute Pancreatitis during COVID-19 Pandemic: An Overview of Patient Demographics, Disease Severity, Management and Outcomes in an Acute District Hospital in Northern Ireland. Cureus. 2021;13(10):e18520.</References>
</References>
</Journal>
</Article>
</ArticleSet>